210 related articles for article (PubMed ID: 6324326)
1. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
[TBL] [Abstract][Full Text] [Related]
3. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022
[TBL] [Abstract][Full Text] [Related]
4. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
5. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
[No Abstract] [Full Text] [Related]
6. [Influence of age factors on the rheological properties of blood in healthy subjects and those with vascular disease].
Artale F; Sergio G; Giunti P; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():431-6. PubMed ID: 6673026
[TBL] [Abstract][Full Text] [Related]
7. [Multi-distributed ischemia and degree of hemorrheological changes].
Sergio G; Artale F; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():427-30. PubMed ID: 6673025
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study on erythrocyte filterability and other hemorrheological parameters in arteriosclerotic vascular disease].
Pernigotti L; Neirotti M
Ric Clin Lab; 1983; 13 Suppl 3():423-6. PubMed ID: 6673024
[TBL] [Abstract][Full Text] [Related]
9. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
10. [Hemorrheological survey in dystrophia myotonica and other muscular dystrophies].
Caimi G; Fierro B; Raimondo D; Frazzetta F; Catania A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():353-5. PubMed ID: 6673013
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
[No Abstract] [Full Text] [Related]
12. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
Petronio G; Scali G; Casa B; Nonis E
Clin Ter; 1980 Aug; 94(4):427-44. PubMed ID: 6257445
[No Abstract] [Full Text] [Related]
13. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
14. [Cellular rheology in obliterative arterial diseases of the lower limbs].
Lombardini R; Ciuffetti G; Palazzetti D; Mannarino E; Pasqualini L; Scarponi AM; Mercuri M; Siepi D
Ric Clin Lab; 1989; 19 Suppl 1():91-3. PubMed ID: 2629095
[No Abstract] [Full Text] [Related]
15. [A new preparation for peripheral arterial occlusive diseases].
Knüchel F
Med Welt; 1982 Jan; 33(1):90. PubMed ID: 6276645
[No Abstract] [Full Text] [Related]
16. [Regional study of the principal hemorheological factors in peripheral obstructive arteriopathy. I].
Artale F; Sergio G; Espureo M; Giunti P; Francisci A; Perego MA
Minerva Cardioangiol; 1981; 29(7-8):367-74. PubMed ID: 7279237
[No Abstract] [Full Text] [Related]
17. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
[No Abstract] [Full Text] [Related]
18. Assignment of hemorheological instruments in the angiologic ambulance: first results and experiences.
Kiesewetter H; Radtke H; Roggenkamp HG; Jung F; Blume J; Schneider R
Biorheology Suppl; 1984; 1():71-4. PubMed ID: 6592000
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of sulocton action in patients with atherosclerotic brain ischemia].
Karwowski B; Jura E; Krasicka J; Kruszewska J; Laskowska-Studniarska W; Szymchel J; Nielubowiczowa H
Neurol Neurochir Pol; 1982; 16(4):237-43. PubMed ID: 6292759
[TBL] [Abstract][Full Text] [Related]
20. Blood rheology changes during bezafibrate treatment.
Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
